Clincosm LogoSign in Get a demo

Dynamic Web-Based Interventions to Improve Update of Preventive Health Recommendations in IBD

Sponsor
Cedars-Sinai Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT05997537
Collaborator
(none)
1,056
Enrollment
1
Location
36.3
Actual Duration (Months)
29.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To understand patient knowledge, attitudes, and beliefs around the uptake of vaccinations and malignancy screening through patient focus groups/qualitative interviews. To develop and pilot an interactive website that will provide customized recommendations for individual patients with IBD and direct them as relevant to five 60-90 second customized, animated videos (influenza, pneumococcal, and zoster vaccinations, bone health, and skin cancer screening). This content will be pilot-tested with patients to fine-tune the educational modules.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1056 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Dynamic Web-Based Interventions to Improve Update of Preventive Health Recommendations in IBD
    Actual Study Start Date :
    Feb 25, 2019
    Actual Primary Completion Date :
    Mar 7, 2022
    Actual Study Completion Date :
    Mar 7, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Uptake of influenza vaccination [Through study completion, no later than March 31, 2020]

      Uptake of influenza vaccination

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • enrollees in the internet-based cohort IBD Partners, age 18 and older
    Exclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Cedars-Sinai Los Angeles California United States 90048

    Sponsors and Collaborators

    • Cedars-Sinai Medical Center

    Investigators

    • Principal Investigator: Gil Melmed, MD, Cedars-Sinai Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Gil Melmed, Clinical Director of Inflammatory Bowel Disease, Cedars-Sinai Medical Center
    ClinicalTrials.gov Identifier:
    NCT05997537
    Other Study ID Numbers:
    • Pro00056067
    First Posted:
    Aug 18, 2023
    Last Update Posted:
    Aug 18, 2023
    Last Verified:
    Aug 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Aug 18, 2023